Theriva biologics to host conference call and webcast to discuss second quarter 2023 operational highlights and financial results

Rockville, md., aug. 01, 2023 (globe newswire) -- theriva biologics (nyse american: tovx), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that it plans to host a conference call on tuesday, august 8, 2023, at 8:30 a.m. et to discuss its financial results for the quarter ended june 30, 2023 and provide a corporate update.
TOVX Ratings Summary
TOVX Quant Ranking